Suntan
|
phenotype |
|
Organ or Tissue Function
|
53
|
94
|
0.100 |
None |
1.000 |
2 |
5
|
2009 |
2018 |
Duration of sleep
|
phenotype |
|
Finding
|
104
|
203
|
0.100 |
None |
1.000 |
2 |
1
|
2019 |
2019 |
Hair Color
|
phenotype |
|
Organism Attribute
|
130
|
312
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Anxiety and fear
|
disease |
|
Mental or Behavioral Dysfunction
|
51
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Motor symptoms
|
phenotype |
|
Sign or Symptom
|
100
|
15
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |
Serum albumin measurement
|
phenotype |
|
Laboratory Procedure
|
433
|
3282
|
0.100 |
None |
1.000 |
1 |
17
|
2013 |
2013 |
psychosocial stressor
|
disease |
|
Mental or Behavioral Dysfunction
|
18
|
3
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Skin toxicity
|
disease |
|
Disease or Syndrome
|
62
|
24
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Familial (FPAH)
|
disease |
|
Disease or Syndrome
|
1075
|
276
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO
|
disease |
|
Finding
|
149
|
527
|
0.100 |
None |
1.000 |
1 |
2
|
2009 |
2009 |
HIV-1, RESISTANCE TO
|
phenotype |
|
Finding
|
147
|
526
|
0.100 |
None |
1.000 |
1 |
2
|
2009 |
2009 |
ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO
|
phenotype |
|
Finding
|
147
|
526
|
0.100 |
None |
1.000 |
1 |
2
|
2009 |
2009 |
AIDS, PROGRESSION TO
|
phenotype |
|
Finding
|
147
|
526
|
0.100 |
None |
1.000 |
1 |
2
|
2009 |
2009 |
SCOLIOSIS, ISOLATED, SUSCEPTIBILITY TO, 3
|
disease |
|
Finding
|
578
|
1158
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Neuropsychiatric syndrome
|
disease |
|
Disease or Syndrome
|
6
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Mental Depression
|
disease |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
1478
|
271
|
0.100 |
None |
1.000 |
10 |
|
2014 |
2019 |
Depressed mood
|
phenotype |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
1461
|
269
|
0.100 |
None |
1.000 |
10 |
|
2014 |
2019 |
Anxiety
|
disease |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
1048
|
287
|
0.070 |
None |
1.000 |
7 |
|
2017 |
2019 |
Abnormal behavior
|
phenotype |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
910
|
121
|
0.060 |
None |
1.000 |
6 |
|
2014 |
2019 |
Addictive Behavior
|
phenotype |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
332
|
56
|
0.040 |
None |
1.000 |
4 |
|
2009 |
2019 |
Behavioral Symptoms
|
group |
Behavior and Behavior Mechanisms
|
Sign or Symptom
|
45
|
9
|
0.020 |
None |
1.000 |
2 |
|
2016 |
2016 |
Stress, Psychological
|
disease |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
199
|
24
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |
Social Anxiety
|
disease |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
57
|
6
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Alcoholic Intoxication, Chronic
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
577
|
441
|
0.070 |
None |
0.857 |
7 |
|
2008 |
2020 |
Nicotine Dependence
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
170
|
178
|
0.040 |
None |
1.000 |
4 |
|
2017 |
2019 |